Enterocolitis, Pseudomembranous: Clinical Trials

2 trials for Enterocolitis, Pseudomembranous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow Enterocolitis, Pseudomembranous: new trials by email Literature Review of Enterocolitis, Pseudomembranous trials Research Report on Enterocolitis, Pseudomembranous

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Alanyl-glutamine - Clostridioides Difficile Infection, Clostridium Difficile Infection
Phase 2RecruitingUniversity of Virginia2602021-06-012024-10-26
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
fecal microbiota - Clostridium Difficile Colitis
Phase 2RecruitingDuke University772016-04-012026-08-27

Narrower conditions

Clostridium Infections (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Digestive System Diseases (2)  ·  Enterocolitis (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Infections (2)  ·  Intestinal Diseases (2)  ·  Clostridium Infections (1)

Interventions

Fecal Microbiota Transplantation (1)  ·  Glutamine (1)  ·  alanylglutamine (1)

Sponsors

Duke University (1)  ·  University of Virginia (1)

Countries

United States (2)

Top investigators

Gary M Cox, MD (1)

Results publications

PMID 37474181